Big Pharma kills signature drug that was at the center of $5.8 billion South S.F. deal By: San Francisco Business Times via Business Journals August 29, 2019 at 17:18 PM EDT AbbVie hoped for big things from Stemcentrx. It got a $5.1 billion write off and the layoff of nearly 200 employees. Read More >>